RedHill Biopharma Ltd.
RDHL
$1.64
-$0.09-5.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.07M | -2.07M | -2.59M | -2.59M | -1.54M |
| Total Depreciation and Amortization | 84.00K | 84.00K | 100.50K | 100.50K | 209.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -214.00K | -214.00K | 818.00K | 818.00K | -2.70M |
| Change in Net Operating Assets | -311.00K | -311.00K | 79.50K | 79.50K | 947.00K |
| Cash from Operations | -2.51M | -2.51M | -1.59M | -1.59M | -3.09M |
| Capital Expenditure | -2.00K | -2.00K | -4.00K | -4.00K | -500.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -2.00K | -4.00K | -4.00K | -500.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -94.50K | -94.50K | -111.00K | -111.00K | -207.00K |
| Issuance of Common Stock | 1.72M | 1.72M | 0.00 | 0.00 | 4.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 369.50K | 369.50K | 25.50K |
| Cash from Financing | 1.63M | 1.63M | 258.50K | 258.50K | 3.95M |
| Foreign Exchange rate Adjustments | 4.50K | 4.50K | 7.50K | 7.50K | -3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -875.50K | -875.50K | -1.33M | -1.33M | 854.00K |